Navigation Links
Bone Growth Protein Also Promotes 'Good' Fat
Date:8/20/2008

Stimulation of brown globules helps burn calories, hints of new ways to treat obesity

WEDNESDAY, Aug. 20 (HealthDay News) -- A protein that induces bone growth also helps promote development of "good" brown fat that helps burn calories and plays a role in fighting obesity, says researchers at the Joslin Diabetes Center in Boston.

They said their finding about the protein, called BMP-7, may help lead to new ways to prevent and treat obesity.

The two main types of fat cells in the body are white and brown, explained study author Yu-Hua Tseng, an assistant investigator in Joslin's Section on Obesity and Hormone Action.

"White fat cells are the 'conventional' form of fat designed to store energy. By contrast, the main role of brown fat is to burn calories by generating heat. Brown fat cells largely disappear by adulthood in humans, but their precursors still remain the body," Tseng said in a Joslin news release.

In laboratory studies of mouse cells, Tseng and colleagues found that BMP-7 drives the precursor cells that give rise to mature brown fat cells. They also found that injecting BMP-7-treated progenitor cells (similar to stem cells) into mice led to increased development of brown fat tissue, and that mice that developed brown fat gained less weight than those that didn't develop brown fat.

The study was published in the Aug. 21 issue of Nature.

The Joslin team hopes this type of research into fat development will lead to new drugs or other treatments for obesity.

"Diet and exercise are still the best approaches for weight reduction in the general population. However, for people who are genetically predisposed to obesity, these approaches may have very little effect," Tseng said.

"As we learn more about the controls of brown fat development, medical interventions to increase energy expenditure by brown fat inducing agents, such as BMP-7, may provide hope to
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. CRDB Bases Growth Strategy on Misys BankFusion Platform
2. Smart Balance to Webcast Presentation at Canaccord Adams Global Growth Conference
3. Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year
4. New Research From Best Practices: Pharmaceutical New Product Planning - Structure and Activities to Drive Growth and Profitability
5. iCAD to Present at Canaccord Adams 28th Annual Global Growth Conference
6. ATS Medical to Participate at the 28th Annual Canaccord Adams Global Growth Conference
7. P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth
8. Vitamin C injections slow tumor growth in mice
9. Cyberonics to Present at Canaccord Adams 28th Annual Global Growth Conference
10. Turned-off cannabinoid receptor turns on colorectal tumor growth
11. ev3 Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... in Cambridge have discovered that the loss of a key ... is the first study to show that this kind of ... in Nature . , The study, led by Dr ... Hurles from the Wellcome Trust Sanger Institute, looked at 300 ... entire genome looking for types of mutation known as copy ...
(Date:12/6/2009)... treatments targeting growth factor, researchers say , , SUNDAY, ... cancer cells from the main tumor to other parts ... known as TGFb, which may prove a promising target ... researchers say. , Previous studies have shown that TGFb ... movement. In this new study, a team from Cancer ...
(Date:12/6/2009)... SUNDAY, Dec. 6 (HealthDay News) -- Early roots of the ... that lived thousands or millions of years ago, new research ... bit of a tiger,s genetic material, scientists say, and a ... day. That tiger, in fact, may have bitten a monkey, ... to its infection of humans. , The finding shouldn,t lead ...
(Date:12/6/2009)... A new study by researchers from the Medical College ... hydroxyurea utilization for pain and other sickle cell disease ... part of both providers and patients were also identified. ... MS, assistant professor of pediatrics at the Medical College ... Wisconsin, will be presented at the American Society of ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:Breast Cancer's Spread Now Better Understood 2Health News:AIDS May Date Back to Ancient Tiger 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5
... seafood per week during pregnancy was associated with higher ... a new study. ,The research is significant ... pregnancy, which state women should not eat more than ... to trace amounts of pollutants in the fish, like ...
... be able to be filtered from human blood saving ... world-first innovation by Queensland University// of Technology scientists. ... membranes for nanofiltration, which are so advanced they have ... blood. ,Associate Professor Huaiyong Zhu, from ...
... $10 million to the Global Fund in the fight ... ,The President made the announcement in a goodwill ... of the Global Fund Africa, set up to fight ... Monday February 12. ,President Obasanjo said, "If ...
... project on magnetic resonance imaging (MRI) could revolutionize ... diagnosing cancer and// other illnesses. ,Naresh ... Florida State University (FSU) and a graduate of ... the University of Colorado and the National Institute ...
... integrated private healthcare provider,// has joined hands with Hayel Saeed ... healthcare system to Yemen. ,The two groups ... in Taiz, Yemen, said a statement by Apollo Group here. ... and also the honorary deputy governor of Taiz State in ...
... smoking are significantly more likely to remain// smoke-free, says ... smokers with acute cardiovascular disease are more likely to ... program. ,“Smoking is the greatest risk factor ... Mohiuddin, MD, FCCP, Creighton University Cardiac Center, Omaha, NE, ...
Other Medicine News:Health News:Fish Intake Linked to Higher IQ in Offspring 2Health News:QUT Scientists on the Way to Sifting Out a Cure for HIV 2Health News:Indian American's Research Could Lead to Improved MRI 2Health News:Intense Cessation Treatment Proves Successful in High-Risk Smokers 2
(Date:12/6/2009)... ORLEANS, Dec. 6 Amgen Inc. (Nasdaq: ... studies on the safety and efficacy of Nplate® ... MDS is a pre-leukemic condition in which early ... unable to mature normally, thereby limiting their ability ... lead to low platelet counts. The results of ...
(Date:12/6/2009)... The FDA has approved new technology ... sooner and faster. The SonoCine Automated Whole-breast Ultrasound ... facility in Arizona - Arizona Breastnet, in Scottsdale. ... breast cancer screening tool to enhance yearly mammography ... for diagnostic purposes - not for screening for ...
(Date:12/6/2009)... Bio Co., Ltd, ( www.rnl.co.kr ) a leading ... announced today that a 46-year-old female, Kang Sook ... cell treatment. Park was suffering from MS (Multiple ... nervous system (brain and spinal cord). ,, ... nerves of the central nervous system degenerate. MS ...
Breaking Medicine Technology:Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10New FDA Approved Breast Cancer Screening Tool 2New FDA Approved Breast Cancer Screening Tool 3Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2IPRO Wins Knowledge Transfer Implementation Federal Contract From AHRQ 57656 1IPRO Wins Knowledge Transfer Implementation Federal Contract From AHRQ 57656 2Pre Existing Health Conditions Cops Firefighters Expectant Dads and Those Suffering From Allergies Acne and Toenail Fungus Are Uninsurable Accor 57653 1Pre Existing Health Conditions Cops Firefighters Expectant Dads and Those Suffering From Allergies Acne and Toenail Fungus Are Uninsurable Accor 57653 2Angina Often Affects Quality of Life 57650 1Angina Often Affects Quality of Life 57650 2
... Dec. 18 Alseres,Pharmaceuticals, Inc., (Nasdaq: ALSE ... subject in the initial stage of the ALTROPANE(R) ... clinical trial program. This,subject was enrolled at the ... of Principal Investigator Dr. Ray L. Watts, MD,Professor ...
... Curemark,s Board of Directors,announced today that Steven M. Schwarz, ... senior scientist and will serve on the company,s Scientific,Advisory ... of,Pediatrics at The Long Island College Hospital and Professor ... Science Center at Brooklyn., "Dr. Schwartz is one ...
Other Medicine Technology:Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 2Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 3Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 4Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 5Curemark Appoints Preeminent Pediatrics Gastroenterologist 2
... tracking and billing. This ... Handheld application, a complete ... CPT™ and ICD-9-CM codes ... Designed for any medical ...
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
... provides safe, effective, current, and ... a quickly accessible format. The ... the latest drugs approved by ... implications are highlighted throughout. This ...
Alphabetically organized monographs on more than 1,000 generic and 3,000 trade name drugs....
Medicine Products: